These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9147846)

  • 1. [Tumor suppressor genes].
    Sedlácek Z; Mares J; Goetz P
    Cas Lek Cesk; 1997 Jan; 136(1):11-6. PubMed ID: 9147846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor suppressors--genes and proteins].
    Lothe RA; Blomhoff HK
    Tidsskr Nor Laegeforen; 1998 May; 118(12):1887-92. PubMed ID: 9638059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor suppressor genes: identification and role in malignant transformation].
    Schäfer R; Klemenz R
    Verh Dtsch Ges Pathol; 1990; 74():328-34. PubMed ID: 1708609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Better understanding of the biology of cancer cells].
    Klein G
    Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
    Staff S; Isola JJ; Johannsson O; Borg A; Tanner MM
    Br J Cancer; 2001 Oct; 85(8):1201-5. PubMed ID: 11710835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
    Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
    Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Better understanding of the biology of cancer cells].
    Klein G
    Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer-protecting genes (tumor-suppressor genes)].
    Olsen J
    Ugeskr Laeger; 2006 Jun; 168(24):2329-31. PubMed ID: 16822412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor suppressor genes with special emphasis on the APC tumor suppressor gene].
    Pećina-Slaus N
    Lijec Vjesn; 1998; 120(7-8):219-27. PubMed ID: 9919881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
    Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
    Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
    Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.